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background:  The electromechanical activation time normalized by cardiac cycle length (%EMAT) measured with an automated acoustic 
cardiography is useful in the prediction of post-discharge cardiovascular outcomes in patients with acute heart failure syndrome (AHFS). The aim of 
this study was to evaluate whether the %EMAT guided post-discharge management improves outcomes in patients with AHFS when compared with 
conventional therapy.
methods:  This prospective single-blind study randomized 194 AHFS subjects (aged 75.4±14.7 years, LVEF 37.5±16.9%, and NTproBNP 
14168.5±21019.8) before discharge to the %EMAT-guided group (n = 102) with the goal to reduce %EMAT to <15%, and the symptom-guided group 
(n = 92) without the knowledge of %EMAT. The primary endpoints were re-hospitalization for HF and CV mortality during 1-year follow-up.
results:  The two groups were well-matched. Through a mean follow-up period of 173±142 days, a significant reduction in the primary endpoints 
was seen in the %EMAT-guided group compared with the symptom-guided group (27 events vs. 39 events, P = 0.02). Kaplan-Meier curves showed 
significant differences in time to first event, favoring the %EMAT-guided group in the total study population (P = 0.03, Fig A), as well as in the pre-
specified subgroup of patients with a pre-discharge %EMAT of >15% (n =79, P=0.04, Fig B).
conclusions:  In patients with AHFS, %EMAT-guided management was superior to the conventional therapy with significantly improved clinical 
outcomes. (NCT01298232). 
